178 related articles for article (PubMed ID: 9285550)
1. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
[TBL] [Abstract][Full Text] [Related]
2. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
[TBL] [Abstract][Full Text] [Related]
3. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
[No Abstract] [Full Text] [Related]
4. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis.
Imashuku S; Naya M; Yamori M; Nakabayashi Y; Hojo M; Kihara A; Tabata Y; Akioka C; Hibi S; Todo S
Bone Marrow Transplant; 1997 May; 19(10):1059-60. PubMed ID: 9169655
[No Abstract] [Full Text] [Related]
5. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Yago K; Itoh M; Shimada H
Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
[TBL] [Abstract][Full Text] [Related]
6. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific cytotoxic T lymphocytes as prophylaxis for Epstein-Barr virus lymphoproliferative disease in pediatric bone marrow transplant recipients.
Norville R; Nance D; Cheshire S
J Pediatr Oncol Nurs; 1997 Oct; 14(4):194-201. PubMed ID: 9322393
[TBL] [Abstract][Full Text] [Related]
9. [Adoptive immune therapy using EBV-specific CTL].
Kuzushima K; Morishima T
Nihon Rinsho; 1997 Feb; 55(2):473-8. PubMed ID: 9046843
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
[TBL] [Abstract][Full Text] [Related]
11. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
Hidalgo M; Lumbreras C; Aguado JM
Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
14. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
[TBL] [Abstract][Full Text] [Related]
15. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder.
Kuzushima K; Kimura H; Hoshino Y; Yoshimi A; Tsuge I; Horibe K; Morishima T; Tsurumi T; Kojima S
J Infect Dis; 2000 Sep; 182(3):937-40. PubMed ID: 10950793
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disorder.
Basgoz N; Preiksaitis JK
Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
[TBL] [Abstract][Full Text] [Related]
19. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
[TBL] [Abstract][Full Text] [Related]
20. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
Swinnen LJ
Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
